The above will happen. Numerous sources of information to show the curve (market penetration); numerous sources showing the move by Governments towards prevention and nutra moving to pharma grade. Just remember, FF is the only ingredient that reduces platelet aggregation without any side-effects. It's primed for the move by Governments as they seek to reduce the costs of treatment and move towards said prevention.
The logic of the argument is sound IMHO. If aspirin is lashed around like candy these days, a safer alternative has to have an attraction to health authorities. Education will take time, but the commercial launches are leading the way. Onwards.
Datafeed and UK data supplied by NETbuilder and Interactive Data.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk!
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.